A detailed history of Invenomic Capital Management LP transactions in Illumina, Inc. stock. As of the latest transaction made, Invenomic Capital Management LP holds 48,224 shares of ILMN stock, worth $6.57 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
48,224
Previous 303,589 84.12%
Holding current value
$6.57 Million
Previous $31.7 Million 80.16%
% of portfolio
0.36%
Previous 1.59%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$105.28 - $135.9 $26.9 Million - $34.7 Million
-255,365 Reduced 84.12%
48,224 $6.29 Million
Q2 2024

Aug 14, 2024

BUY
$101.05 - $133.57 $19.5 Million - $25.8 Million
192,895 Added 174.26%
303,589 $31.7 Million
Q1 2024

May 15, 2024

SELL
$127.73 - $147.2 $29.9 Million - $34.5 Million
-234,303 Reduced 67.91%
110,694 $15.2 Million
Q4 2023

Feb 14, 2024

BUY
$92.79 - $142.53 $32 Million - $49.2 Million
344,997 New
344,997 $48 Million
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $16.4 Million - $21.1 Million
92,605 New
92,605 $17.7 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Invenomic Capital Management LP Portfolio

Follow Invenomic Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Invenomic Capital Management LP with notifications on news.